SCHEMBL9865432

SCHEMBL9865432

O=C(NC(=NCCCc1c[nH]cn1)NCCC(c1ccc(F)cc1)c1ccccn1)c1ccccc1

nearest known ligand 0.52

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
NPY1R P25929 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9867594 0.96 NPY1R (0.40) NPY1R
SCHEMBL9867599 0.94 NPY1R (0.39) NPY1R
SCHEMBL9865305 0.94 NPY1R (0.41) NPY1R
SCHEMBL9865426 0.94 NAMPT (0.38) NPY1R
SCHEMBL7287078 0.92 NPY1R (0.40) NPY1R
SCHEMBL7297991 0.92 NPY1R (0.39) NPY1R
SCHEMBL9867526 0.92
SCHEMBL9865695 0.92 PMP22 (0.40) NPY1R
SCHEMBL9866078 0.90 EPHX2 (0.39)
SCHEMBL9866163 0.89 RAB9A (0.37) NPY1R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5026625-A Photoinitiators for polymerization of ethylenically unsaturated compounds CIBA-GEIGY CORPORATION (US) 1991-06-25 US disclosed
US-5021431-A H-1 antagonist, h-2 agonist for treating hypertension, cardiac disease or arterial occlusion HEUMANN PHARMA GMBH & CO. (DE) 1991-06-04 US disclosed
EP-0199845-B1 IMIDAZOLYLALKYLGUANIDIN DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM HEUMANN PHARMA GMBH & CO (DE) 1990-08-01 EP disclosed
EP-0199845-A1 Imidazolylalkylguanidin derivatives, process for their preparation and pharmaceutical compositions containing them HEUMANN PHARMA GMBH & CO (DE) 1986-11-05 EP disclosed